Ten-year clinical outcomes of everolimus- and biolimus-eluting coronary stents vs. everolimus-eluting bioresorbable vascular scaffolds—insights from the EVERBIO-2 trial

BackgroundBioresorbable vascular scaffolds (BVSs) have been developed as a potential solution to mitigate late complications associated with drug-eluting metallic stents (DESs) in percutaneous coronary intervention for coronary artery disease. While numerous studies have compared BVSs to DESs, none...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Samir Bengueddache, Malica Cook, Sonja Lehmann, Diego Arroyo, Mario Togni, Serban Puricel, Stephane Cook
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2024-09-01
Edice:	Frontiers in Cardiovascular Medicine
Témata:	percutaneous coronary intervention (PCI) drug-eluting stent (DES) bioresorbable vascular scaffold (BVS) randomized clinical trial coronary artery disease
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fcvm.2024.1426348/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!